Lamattina John L insider trades
Lamattina John L has filed 14 Form 4s with the SEC that we hold, for Ligand Pharmaceuticals INC (LGND) (Director) and Immunome Inc. (IMNM) (Director). Across all of them we count 0 purchases worth $0 and 9 sales worth $3.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($2.4M). The largest single trade was a sale of 3,405 shares of Ligand Pharmaceuticals INC worth $856.8K, dated 2026-06-10. The first filing on our record is dated 2021-11-17 and the latest 2026-06-12.
Ligand Pharmaceuticals INC (LGND)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-16 | S, sale reported on Form 4 | 4,835 | $782.6K | 2021-11-17 |
| 2024-11-27 | S, sale reported on Form 4 | 2,406 | $297.5K | 2024-12-02 |
| 2025-11-07 | S, sale reported on Form 4 | 2,034 | $417.9K | 2025-11-12 |
| 2025-11-07 | S, sale reported on Form 4 | 2,145 | $440.7K | 2025-11-12 |
| 2026-03-06 | S, sale reported on Form 4 | 2,161 | $433.8K | 2026-03-31 |
| 2026-06-10 | S, sale reported on Form 4 | 257 | $63.5K | 2026-06-12 |
| 2026-06-10 | S, sale reported on Form 4 | 3,405 | $856.8K | 2026-06-12 |
| 2026-06-10 | S, sale reported on Form 4 | 697 | $173.9K | 2026-06-12 |
| 2026-06-10 | S, sale reported on Form 4 | 232 | $57.6K | 2026-06-12 |
Immunome Inc. (IMNM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1216074) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms